Equity · Healthcare
AHCO
NASDAQAdaptHealth (AHCO)
The line runs 5.71 USD on 13 August through 7.73 USD on 10 November, on a scale from 5 to 8. Days the market did not trade hold the previous close, flat.
- Market cap
- 1.1B USD
- Revenue, year to Dec 2025
- 3.2B USD
- EPS, diluted, year to Dec 2025
- −0.52 USD
- 52-week range
- 5.22 USD – 13.39 USD
- Avg volume
- 188.5K
as of Nov 10, 2026
Have AdaptHealth (AHCO) insiders bought or sold shares recently?
In the 90 days to 11 Nov 2026, no AdaptHealth insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4).
Form 4, 90 days to 11 Nov 2026, newest Form 4 filing 9 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 09 Sep 2026 | CURRIE HARRISS TCHIEF FINANCIAL OFFICER | Award | 141,372 |
Which funds hold AdaptHealth (AHCO)?
8 of the 45 institutional funds we track reported a AdaptHealth position for the quarter ended 30 Jun 2026 — a combined 32.9M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Renaissance Technologies | Added | 764,342 | 8.0M USD | +234.7% |
| AQR Capital Management | Held (±25%) | 761,857 | 7.9M USD | −21.2% |
| Citadel Advisors | Added | 484,652 | 5.1M USD | +275.4% |
| D. E. Shaw & Co. | Held (±25%) | 407,617 | 4.2M USD | +21.5% |
| Millennium Management | Trimmed | 347,920 | 3.6M USD | −47.4% |
| Man Group | Trimmed | 290,028 | 3.0M USD | −30.0% |
| Balyasny Asset Management | Trimmed | 74,969 | 781K USD | −51.7% |
| Two Sigma Investments | Added | 27,401 | 286K USD | +45.7% |
| Marshall Wace | Exited |
Have members of Congress traded AdaptHealth (AHCO)?
The most recent congressional trade disclosed in AdaptHealth is a sale by Kevin Hern (house, OK), dated 06 Apr 2023.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 06 Apr 2023 | Kevin Hernhouse · Republican–OK | Sale | 1K USD–15K USD | 35 days |
| 30 Nov 2022 | Susie Leehouse · Democrat–NV | Sale | 1K USD–15K USD | 29 days |
| 22 Apr 2022 | Kevin Hernhouse · Republican–OK | Sale | 1K USD–15K USD | 20 days |
| 25 Aug 2021 | Kevin Hernhouse · Republican–OK | Purchase | 100K USD–250K USD | 21 days |
| 20 May 2021 | Kevin Hernhouse · Republican–OK | Purchase | 1K USD–15K USD | 26 days |
| 09 Feb 2021 | Susie Leehouse · Democrat–NV | Purchase | 1K USD–15K USD | 30 days |
| 05 Jan 2021 | Susie Leehouse · Democrat–NV | Purchase | 1K USD–15K USD | 36 days |
What has been filed or recorded for AdaptHealth (AHCO)?
The filings we hold for AdaptHealth, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −1.13 USD | Revenue $746M |
| 30 Sep 2026 | Financials | Total assets | 4.2B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 1.2B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.99 USD | Revenue $740M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.12 USD | Revenue $820M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.52 USD | Revenue $3.24B |
| 31 Dec 2025 | Financials | Revenue | 3.2B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −70.8M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.52 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.17 USD | Revenue $672M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.10 USD | Revenue $657M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.05 USD | Revenue $778M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 0.61 USD | Revenue $3.26B |
What do people ask about AdaptHealth (AHCO)?
What did AdaptHealth shares close at?7.73
AdaptHealth closed at 7.73 USD on 10 Nov 2026, up 5.17% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is AdaptHealth’s market cap?1.1B
AdaptHealth is worth 1.1B USD by market value as of 10 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is AdaptHealth’s revenue?3.2B
AdaptHealth reported revenue of 3.2B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have AdaptHealth insiders bought or sold shares recently?1 filing
In the 90 days to 11 Nov 2026, no AdaptHealth insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4). See Insiders
Which funds own AdaptHealth?8 of 45
8 of the 45 funds we track reported a AdaptHealth position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, AQR Capital Management and Citadel Advisors. See Funds
Have members of Congress traded AdaptHealth?7 trades
Yes. 7 trades in AdaptHealth appear in the congressional disclosures we hold; the latest is a sale by Kevin Hern (House, OK) dated 6 Apr 2023, filed 11 May 2023. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did AdaptHealth last report earnings?−1.13
AdaptHealth last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −1.13 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Susie Lee: Eric Connolly, Public domain; Kevin Hern: U.S. House of Representatives, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings